KURA:NASDAQ - KURA ONCOLOGY - Cancer biopharmaceutical company 롱

Kura Oncology, Inc.NASDAQ

설명

⋅ 2020년 11월 11일 오전 3시 53분

KURA is up 500% from its March lows and running well. It has had a pullback and recovery and then an additional momentum bump on earnings. Could be worth a watch.